Topics

Psychedelic drug MDMA may reawaken 'critical period' in brain to help treat PTSD

20:00 EDT 3 Apr 2019 | AAAS

(Johns Hopkins Medicine) Johns Hopkins neuroscientists have found that the psychedelic drug MDMA reopens a kind of window, called a 'critical period,' when the brain is sensitive to learning the reward value of social behaviors. The findings, reported April 3 in Nature, may explain why MDMA may be helpful in treating people with post-traumatic stress disorder (PTSD).

Original Article: Psychedelic drug MDMA may reawaken 'critical period' in brain to help treat PTSD

NEXT ARTICLE

More From BioPortfolio on "Psychedelic drug MDMA may reawaken 'critical period' in brain to help treat PTSD"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Anxiety Disorders
Anxiety is caused by stress. It is a natural reaction, and is beneficial in helping us deal with tense situations and pressure. It is deterimental when is becomes an excessive, irrational dread of everyday situations. The most common types of anxiety di...

Mental Health
Adhd Anorexia Depression Dyslexia Mental Health Psychiatry Schizophrenia Stress Mental health, although not being as obvious as physical health, is very important, causing great unhappiness to those affected, causing add...